Physician profile
John Andrew Sharp
NPI 1205827979
$12,921.28
in general payments reported to CMS, 2019-2025
12 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,619 · 2020: $803 · 2021: $1,607 · 2022: $4,495 · 2023: $704 · 2024: $3,453 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,069 · Food and Beverage: $1,253 · Education: $74.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,069.01 |
| Food and Beverage | $1,253.38 |
| Education | $74.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $7,040.95 | 2019-2025 | |
| Stryker Corporation | $1,283.75 | 2020-2024 | 7 X 23mm Citrelock Implant, Infinity Adaptis, Citrefix |
| Anika Therapeutics, INC. | $1,129.39 | 2021-2022 | |
| Paragon 28, INC. | $1,119.40 | 2021-2025 | Hammertube Sterile Implant Kits, Portfolio, Ankle Fracture |
| Arthrex, INC. | $1,104.28 | 2024-2025 | |
| Treace Medical Concepts, INC. | $927.74 | 2022-2023 | |
| Wright Medical Technology, INC. | $112.14 | 2020 | |
| Acera Surgical, INC. | $82.28 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $61.43 | 2019 | |
| Globus Medical, INC. | $30.34 | 2023 | Ankle Fracture System |
| Avanos Medical | $15.65 | 2020 | |
| Fidia Pharma USA INC. | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.